News | November 10, 2021
Moderna seeks approval from EMA for its Covid-19 vaccine for children between 6-11 years
The submission is based on Phase 2/3 study of mRNA-1273 in children ages 6 to 11
The submission is based on Phase 2/3 study of mRNA-1273 in children ages 6 to 11
It is the world’s first DNA-based Covid vaccine
The process is completed with the help of a balloon at a low temperature so that other cells are undamaged and the patient can return home the next day
The solution helps the pharma enterprises drive efficiencies, save costs, and increase productivity
The release of this batch will secure the supply for hospitals and cancer centres that are involved in the clinical trials managed by the company
The youngest child in India to survive ECMO after undergoing bone marrow transplant for a rare disease
This capability programme aims to upskill 5000 nurses across the country in the next year by converting the current modules into an e-learning one
It is the first company to launch Remogliflozin, Vildagliptin and Metformin combination
A total of Rs 17,691.08 cr. invested in 157 new approved medical colleges since 2014
Subscribe To Our Newsletter & Stay Updated
